B537--Neuropathology Testing Detroit VAMC
Closed Special Notice Posted
- Solicitation number
- 36C25024Q0084
- Agency
- Veterans Integrated Service Network 10 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice from the Department of Veterans Affairs intends to negotiate a sole source contract for neuropathology testing services with TheraPath Partners LLC. The notice provides details for a contract to provide specialized testing associated with muscle, nerve, and epidermal biopsies for neuromuscular disorders, neuropathy, and small fiber neuropathy.
The firm fixed price contract would be for 10 months of preventative maintenance services for Neuropathology Testing Systems. Responses to the notice must show clear and convincing evidence that competition would be advantageous to the government and are due no later than November 2, 2023 by 11:59 PM EST. Eligible contractors must have the mandatory Clinical Laboratory Improvement Amendment licenses and accreditation to perform the required specialized testing services. The anticipated sole source contract would provide neuropathology testing services to support Veterans Affairs healthcare facilities in analyzing biopsy samples.
Notice text
Notice of Intent to Sole Source Requirement
The Department of Veterans Affairs, VA Healthcare System, Network 10 Contracting Office intends to negotiate a sole source contract for preventive maintenance service for Neuropathology Testing Systems under Simplified Acquisition Procedures and the authority of FAR Part 6.302-1, Only One Responsible Source for the following services listed below. The associated NAICS code for this is 541380. The vendor will be TheraPath Partners LLC 545 W 45th St Fl 7, New York, New York 10036-3409
Description of services: Neuropathology Services for the specialized testing associated with muscle, nerve, and epidermal biopsies for neuromuscular disorders, neuropathy, and small fiber neuropathy.
TheraPath has the mandatory (CLIA) Clinical Laboratory Improvement Amendment licenses and/or accredited by the College of American Pathologist, the Center for Disease Control, Medicare and/or state regulatory agencies as mandated by federal and state statutes.
A firm fixed price contract for 10 months is anticipated and will be awarded. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source.
Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Documentation and Clinical Laboratory Improvement Amendments (CLIA) Licenses required. Responses must be received NLT 11:59 PM EST on 02 NOV 2023. No telephonic inquiries shall be accepted.  All responses must be e-mailed to the contracting officer.
This notice of intent is not a request for competitive proposals. It is not a solicitation or request for offers.
Attachments
| File | Type | Posted |
|---|---|---|
| 36C25024Q0084_1.docx | DOCX document |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity